Proton beam radiation therapy for head and neck malignancies

Current Oncology Reports

Volumn 12, Issue 3, 2010, Pages 202-207

  Frank, Steven J ^a   Selek, Ugur ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Conformal radiotherapy; Head and neck neoplasms; Intensity modulated radiotherapy; Particle beam therapy; Radiation oncology

Indexed keywords

CANCER RADIOTHERAPY; CHONDROSARCOMA; CHORDOMA; ESTHESIONEUROBLASTOMA; EYE CANCER; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; NASOPHARYNX CANCER; OROPHARYNX TUMOR; PARANASAL SINUS TUMOR; PHOTON THERAPY; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; REVIEW; SKULL BASE TUMOR;

HEAD AND NECK NEOPLASMS; HUMANS; PROTONS;

EID: 77952236930     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-010-0089-0     Document Type: Review

References (49)

1. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: head and neck cancers. NCCN v.1.2009. Accessible at http://www.nccn.org. Accessed January 2010.
2. GE Kim HC Park KC Keum, et al. 1999 Adenoid cystic carcinoma of the maxillary antrum Am J Otolaryngol 20 77 84 10.1016/S0196-0709(99)90015-7 1:STN:280:DyaK1M3hslyjtA%3D%3D 10203156 (Pubitemid 29157672)
3. P Lavertu JK Roberts DH Kraus, et al. 1989 Squamous cell carcinoma of the paranasal sinuses: the Cleveland Clinic experience 1977-1986 Laryngoscope 99 1130 1136 10.1288/00005537-198911000-00005 1:STN:280:DyaK3c%2Fkt12nsA%3D%3D 2811551 (Pubitemid 19274804)
4. WM Mendenhall CG Morris RJ Amdur, et al. 2004 Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck Head Neck 26 154 162 10.1002/hed.10380 14762884 (Pubitemid 38160449)
5. B Vikram EW Strong JP Shah, et al. 1984 Radiation therapy in adenoid-cystic carcinoma Int J Radiat Oncol Biol Phys 10 221 223 1:STN:280:DyaL2c7mtFChsw%3D%3D 6323361 (Pubitemid 14131624)
6. AS Garden RS Weber WH Morrison, et al. 1995 The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation Int J Radiat Oncol Biol Phys 32 619 626 10.1016/0360-3016(95)97766-T 1:STN:280:DyaK2MzhtVajtA%3D%3D 7790247
7. TS Katz WM Mendenhall CG Morris, et al. 2002 Malignant tumors of the nasal cavity and paranasal sinuses Head Neck 24 821 829 10.1002/hed.10143 12211046 (Pubitemid 34913253)
8. A Takeda N Shigematsu S Suzuki, et al. 1999 Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity Int J Radiat Oncol Biol Phys 44 599 605 10.1016/S0360-3016(99)00057-7 1:STN:280:DyaK1M3ns1SntA%3D%3D 10348290 (Pubitemid 29258435)
9. JN Waldron B O'Sullivan P Warde, et al. 1998 Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy Int J Radiat Oncol Biol Phys 41 361 369 1:STN:280:DyaK1c3mvVelug%3D%3D 9607352 (Pubitemid 28243548)
10. JT Parsons FJ Bova CR Fitzgerald, et al. 1994 Severe dry-eye syndrome following external beam irradiation Int J Radiat Oncol Biol Phys 30 775 780 1:STN:280:DyaK2M%2FkvFOjuw%3D%3D 7960978
11. AM Chen ME Daly MK Bucci, et al. 2007 Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 69 141 147 17459609
12. ME Daly AM Chen MK Bucci, et al. 2007 Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses Int J Radiat Oncol Biol Phys 67 151 157 17189068 (Pubitemid 44959503)
13. BS Hoppe LD Stegman MJ Zelefsky, et al. 2007 Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience Int J Radiat Oncol Biol Phys 67 691 702 17161557
14. AW Chan P Pommier DG Deschler, et al. 2004 Change in patterns of relapse after combined proton and photon irradiation for locally advanced paranasal sinus cancer Int J Radiat Oncol Biol Phys 60 S320 10.1016/j.ijrobp.2004.07.135
15. P Pommier NJ Liebsch DG Deschler, et al. 2006 Proton beam radiation therapy for skull base adenoid cystic carcinoma Arch Otolaryngol Head Neck Surg 132 1242 1249 10.1001/archotol.132.11.1242 17116822 (Pubitemid 44800140)
16. DC Weber AW Chan S Lessell, et al. 2006 Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons Radiother Oncol 81 243 249 10.1016/j.radonc.2006.09.009 17050017 (Pubitemid 44856004)
17. DI Rosenthal JL Barker Jr AK El-Naggar, et al. 2004 Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype Cancer 101 2567 2573 10.1002/cncr.20693 15517582 (Pubitemid 39532286)
18. H Nishimura T Ogino M Kawashima, et al. 2007 Proton-beam therapy for olfactory neuroblastoma Int J Radiat Oncol Biol Phys 68 758 762 17398027 (Pubitemid 46818736)
19. BS Chera R Malyapa D Louis, et al. 2009 Proton therapy for maxillary sinus carcinoma Am J Clin Oncol 32 296 303 10.1097/COC.0b013e318187132a 19433966
20. KR Kozak J Adams SJ Krejcarek, et al. 2009 A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas Int J Radiat Oncol Biol Phys 74 179 186 19019562
21. N Lee P Xia JM Quivey, et al. 2002 Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 12 22 10.1016/S0360-3016(02)02859-6 12007936 (Pubitemid 34787877)
22. SL Wolden WC Chen DG Pfister, et al. 2006 Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience Int J Radiat Oncol Biol Phys 64 57 62 15936155 (Pubitemid 41831209)
23. MK Kam PM Teo RM Chau, et al. 2004 Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience Int J Radiat Oncol Biol Phys 60 1440 1450 15590175 (Pubitemid 39601861)
24. MK Kam SF Leung B Zee, et al. 2007 Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 4873 4879 10.1200/JCO.2007.11. 5501 17971582 (Pubitemid 350220416)
25. G Noel G Boisserie B Dessard-Diana, et al. 2002 Comparison of dose-volume histograms of two-conformal irradiation techniques used for treatment of T2N0M0 nasopharyngeal cancer, one with association of photons and protons with photons alone Cancer Radiother 6 337 348 1:STN:280:DC%2BD38jktFehsA%3D%3D 12504770 (Pubitemid 36054858)
26. L Widesott A Pierelli C Fiorino, et al. 2008 Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation Int J Radiat Oncol Biol Phys 72 589 596 18793962
27. R Lin JD Slater LT Yonemoto, et al. 1999 Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy-dose-volume histogram analysis Radiology 213 489 494 1:STN:280:DC%2BD3c%2FhvV2hug%3D%3D 10551231
28. AP Brown MM Urie R Chisin, et al. 1989 Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning Int J Radiat Oncol Biol Phys 16 1607 1614 1:STN:280:DyaL1M3lsVKrtg%3D%3D 2542199
29. Patel S, Adams JA, Chan AW: Nasopharynx. In Proton and Heavier Charged Particle Radiotherapy. Edited by Delaney T, Kooy H. Baltimore, MD: Lippincott Williams and Wilkins; 2007:98-107.
30. U Selek AS Garden WH Morrison, et al. 2004 Radiation therapy for early-stage carcinoma of the oropharynx Int J Radiat Oncol Biol Phys 59 743 751 15183477
31. DA Fein WR Lee WR Amos, et al. 1996 Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience Int J Radiat Oncol Biol Phys 34 289 296 1:STN:280:DyaK287lvVOmtQ%3D%3D 8567328
32. DA Fein WM Mendenhall JT Parsons, et al. 1993 Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation Int J Radiat Oncol Biol Phys 26 751 757 1:STN:280:DyaK3szks1antw%3D%3D 8344842
33. JT Gwozdz WH Morrison AS Garden, et al. 1997 Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa Int J Radiat Oncol Biol Phys 39 127 135 1:STN:280:DyaK2svksVaitw%3D%3D 9300747
34. KS Chao G Ozyigit AI Blanco, et al. 2004 Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume Int J Radiat Oncol Biol Phys 59 43 50 15093897
35. AS Garden WH Morrison PF Wong, et al. 2007 Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 67 438 444 17141972
36. FF de Arruda DR Puri J Zhung, et al. 2006 Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 64 363 373 15925451
37. NY Lee FF de Arruda DR Puri, et al. 2006 A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 966 974 17145527
38. JD Slater LT Yonemoto DW Mantik, et al. 2005 Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique Int J Radiat Oncol Biol Phys 62 494 500 15890592
39. PT Tai P Craighead F Bagdon 1995 Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques Cancer 75 749 756 10.1002/1097-0142(19950201)75:3<749::AID- CNCR2820750302>3.0.CO;2-D 1:STN:280:DyaK2M7ivFShuw%3D%3D 7828124
40. E Gay LN Sekhar E Rubinstein, et al. 1995 Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients Neurosurgery 36 887 896 10.1097/00006123-199505000-00001 1:STN:280:DyaK2Mzht1Wqsw%3D%3D 7791978 discussion 896-887
41. J Debus D Schulz-Ertner L Schad, et al. 2000 Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base Int J Radiat Oncol Biol Phys 47 591 596 10.1016/S0360-3016(00)00464-8 1:STN:280: DC%2BD3c3pvVKruw%3D%3D 10837940 (Pubitemid 30317475)
42. F Zorlu M Gurkaynak F Yildiz, et al. 2000 Conventional external radiotherapy in the management of clivus chordomas with overt residual disease Neurol Sci 21 203 207 10.1007/s100720070077 1:STN:280:DC%2BD3M3gtlansQ%3D%3D 11214658 (Pubitemid 33621546)
43. JE Munzenrider NJ Liebsch 1999 Proton therapy for tumors of the skull base Strahlenther Onkol 175 57 63 10.1007/BF03038890 10394399
44. EB Hug LN Loredo JD Slater, et al. 1999 Proton radiation therapy for chordomas and chondrosarcomas of the skull base J Neurosurg 91 432 439 10.3171/jns.1999.91.3.0432 1:STN:280:DyaK1MzpslCiuw%3D%3D 10470818
45. G Noel L Feuvret V Calugaru, et al. 2005 Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams Acta Oncol 44 700 708 10.1080/02841860500326257 16227160 (Pubitemid 41547070)
46. C Ares EB Hug AJ Lomax, et al. 2009 Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report Int J Radiat Oncol Biol Phys 75 1111 1118 19386442 In this study, 5-year local control rates were 81% for chordomas and 94% for chondrosarcomas and the freedom from high-grade (grade 3 and 4) toxic effects was 94%.
47. M Amichetti M Cianchetti D Amelio, et al. 2009 Proton therapy in chordoma of the base of the skull: a systematic review Neurosurg Rev 32 403 416 10.1007/s10143-009-0194-4 19319583 This article provides a comprehensive review of the outcomes of skull base chordomas using proton beam radiation therapy.
48. R Miralbell L Cella D Weber A Lomax 2000 Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams Int J Radiat Oncol Biol Phys 47 1111 1119 1:STN:280:DC%2BD3czitlamtg%3D%3D 10863085
49. M Brada M Phijls-Johnannesma D Ruysshcer 2007 Proton therapy in clinical practice: current clinical evidence J Clin Oncol 25 965 970 10.1200/JCO.2006.10. 0131 17350945 This article reports that, for patients presenting with ocular melanoma, seven studies (n∈=∈7355) showed a 5-year cause-specific survival rate of 85%, with a 90% eye-preservation rate and a 97% local control rate. (Pubitemid 350002862)